- Lobbying
- Lobbying by National Assn for Biomedical Research
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Dennis Potter | Staff Asst/LC, Senator Gramm |
Barton Gordon | U.S. Congressman |
Slade Gorton | U.S. Senator |
James Walsh | U.S. Congressman |
Nicholas Leibham | Senior Aide/Special Assistant, Rep Abercrombie; Special Assistant, Rep Ackerman |
Slade Gordon | U.S. Senator |
Steven Valentine | Deputy Assistant Attorney General, DOJ; General Counsel/LD, Senator Smith |
Scott Nelson | Sen. Byron Dorgan - Asst. Chief of Staff, Leg, Assistant, Dep. Chief of Staff; Dept. of Energy - Deputy Director of Scheduling & Advance |
Scott Aliferis | Legislative Director, Rep. Upton |
James Sartucci | LD, Senator Lott; Professional Staff, Senate Committee on Commerce, Science and Transportation; Coast Guard Fellow, Senate Committee on Commerce, Science and Transportation |
Jeffrey Denham | U.S. Congressman |
W. Dennis Stephens | n/a |
Daniel Ritter | n/a |
Emanuel Rouvelas | n/a |
Tim Peckinpaugh | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Executive Office of the President (EOP)
Agriculture - Dept of (USDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Executive Office of the President (EOP)
Office of the Vice President of the United States
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Transportation - Dept of (DOT)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to medical research.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate